Literature DB >> 19523694

Increasing aqueous solubility of curcumin for improving bioavailability.

Biji T Kurien, R Hal Scofield.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19523694      PMCID: PMC7304285          DOI: 10.1016/j.tips.2009.04.005

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  10 in total

1.  Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer.

Authors:  R A Sharma; H R McLelland; K A Hill; C R Ireson; S A Euden; M M Manson; M Pirmohamed; L J Marnett; A J Gescher; W P Steward
Journal:  Clin Cancer Res       Date:  2001-07       Impact factor: 12.531

2.  Curcumin/turmeric solubilized in sodium hydroxide inhibits HNE protein modification--an in vitro study.

Authors:  Biji T Kurien; R Hal Scofield
Journal:  J Ethnopharmacol       Date:  2006-10-13       Impact factor: 4.360

3.  In vitro modification of solid phase multiple antigenic peptides/autoantigens with 4-hydroxy-2-nonenal (HNE) provide ideal substrates for detection of anti-HNE antibodies and peptide antioxidants.

Authors:  Biji T Kurien; R Hal Scofield
Journal:  J Immunol Methods       Date:  2005-08       Impact factor: 2.303

4.  Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

Authors:  A L Cheng; C H Hsu; J K Lin; M M Hsu; Y F Ho; T S Shen; J Y Ko; J T Lin; B R Lin; W Ming-Shiang; H S Yu; S H Jee; G S Chen; T M Chen; C A Chen; M K Lai; Y S Pu; M H Pan; Y J Wang; C C Tsai; C Y Hsieh
Journal:  Anticancer Res       Date:  2001 Jul-Aug       Impact factor: 2.480

5.  Improving the solubility and pharmacological efficacy of curcumin by heat treatment.

Authors:  Biji T Kurien; Anil Singh; Hiroyuki Matsumoto; R Hal Scofield
Journal:  Assay Drug Dev Technol       Date:  2007-08       Impact factor: 1.738

6.  Heat-solubilized curcumin should be considered in clinical trials for increasing bioavailability.

Authors:  Biji T Kurien; R Hal Scofield
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

7.  Phase II trial of curcumin in patients with advanced pancreatic cancer.

Authors:  Navneet Dhillon; Bharat B Aggarwal; Robert A Newman; Robert A Wolff; Ajaikumar B Kunnumakkara; James L Abbruzzese; Chaan S Ng; Vladimir Badmaev; Razelle Kurzrock
Journal:  Clin Cancer Res       Date:  2008-07-15       Impact factor: 12.531

Review 8.  Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets.

Authors:  Bharat B Aggarwal; Bokyung Sung
Journal:  Trends Pharmacol Sci       Date:  2008-12-26       Impact factor: 14.819

9.  Increasing the solubility of the nutraceutical curcumin by heat and inhibition of oxidative modification.

Authors:  Biji T Kurien; R Hal Scofield
Journal:  Mol Nutr Food Res       Date:  2009-02       Impact factor: 5.914

10.  Dose escalation of a curcuminoid formulation.

Authors:  Christopher D Lao; Mack T Ruffin; Daniel Normolle; Dennis D Heath; Sandra I Murray; Joanne M Bailey; Martha E Boggs; James Crowell; Cheryl L Rock; Dean E Brenner
Journal:  BMC Complement Altern Med       Date:  2006-03-17       Impact factor: 3.659

  10 in total
  6 in total

1.  Effect on pro-inflammatory and antioxidant genes and bioavailable distribution of whole turmeric vs curcumin: Similar root but different effects.

Authors:  Robert C G Martin; Harini S Aiyer; Daniel Malik; Yan Li
Journal:  Food Chem Toxicol       Date:  2011-11-04       Impact factor: 6.023

2.  Heat-solubilized curry spice curcumin inhibits antibody-antigen interaction in in vitro studies: a possible therapy to alleviate autoimmune disorders.

Authors:  Biji T Kurien; Anil D'Souza; R Hal Scofield
Journal:  Mol Nutr Food Res       Date:  2010-08       Impact factor: 5.914

3.  Curcumin mediated suppression of nuclear factor-κB promotes chondrogenic differentiation of mesenchymal stem cells in a high-density co-culture microenvironment.

Authors:  Constanze Buhrmann; Ali Mobasheri; Ulrike Matis; Mehdi Shakibaei
Journal:  Arthritis Res Ther       Date:  2010-07-01       Impact factor: 5.156

4.  Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy.

Authors:  Amalendu P Ranjan; Anindita Mukerjee; Lawrence Helson; Jamboor K Vishwanatha
Journal:  J Nanobiotechnology       Date:  2012-08-31       Impact factor: 10.435

5.  Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes.

Authors:  Murali Mohan Yallapu; Mara C Ebeling; Neeraj Chauhan; Meena Jaggi; Subhash C Chauhan
Journal:  Int J Nanomedicine       Date:  2011-11-08

6.  Bisdemethoxycurcumin inhibits PDGF-induced vascular smooth muscle cell motility and proliferation.

Authors:  Yinan Hua; Julia Dolence; Shalini Ramanan; Jun Ren; Sreejayan Nair
Journal:  Mol Nutr Food Res       Date:  2013-04-02       Impact factor: 5.914

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.